• Info
  • Insider Ownership

Insider Trading & Ownership of Thomas D. Carey

Location
Hingham, MA
Summary
The estimated net worth of Thomas D. Carey is at least $1,081,122 dollars as of 02 Mar 2026. Thomas D. Carey is the Director of STANDARD BIOTOOLS INC. and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $692.2K. Thomas D. Carey is the Director of EXACT SCIENCES CORP and owns shares of EXACT SCIENCES CORP (EXAS) stock worth about $389K.
Signature
/s/ Thomas D. Carey by Tomone Tanaka, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Thomas D. Carey and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Thomas D. Carey has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,081,122.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: STANDARD BIOTOOLS INC. ($692,160).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Thomas D. Carey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LAB STANDARD BIOTOOLS INC. Director $692,160 26 Feb 2026
EXAS EXACT SCIENCES CORP Director $388,962 02 Jun 2021
SLGC SomaLogic, Inc. Director 05 Jan 2024

Insider Transactions Reported by Thomas D. Carey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored